OPPORTUNISTIC INFECTION side effect
What is OPPORTUNISTIC INFECTION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
OPPORTUNISTIC INFECTION and Recently Reported Side Effects
OPPORTUNISTIC INFECTION and 15 most Active Side Effect polls
OPPORTUNISTIC INFECTION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with OPPORTUNISTIC INFECTION
ESCITALOPRAM ESERTIA HUMIRA KALETRA METHOTREXATE NATALIZUMAB PROGRAF RITUXAN TEMODAL TYSABRITysabri Side Effects Report #5679101-6
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Mar 10, 2008. Female patient, 37 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5683488-8
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2008. Female patient, 37 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, staphylococcal sepsis, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5567778-5
Consumer or non-health professional from UNITED STATES reported NATALIZUMAB problem on Dec 03, 2007. Male patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5508221-1
KALETRA problem was reported by a Physician from ROMANIA on Nov 01, 2007. Male patient, 53 years of age, weighting 134.5 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pancytopenia, pyrexia, . KALETRA dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient was hospitalized. Patient died on 09/08/2007.
Tysabri Side Effects Report #5766343-4
Physician from UNITED STATES reported TYSABRI problem on May 24, 2008. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, unevaluable event, urinary tract infection, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient died on 01/01/2008.
Tysabri Side Effects Report #5792241-6
TYSABRI problem was reported by a Physician from UNITED STATES on June 09, 2008. Female patient, 60 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pneumonia, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5695476-6
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Mar 20, 2008. Female patient, 37 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, staphylococcal abscess, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Prograf Side Effects Report #5705501-1
PROGRAF problem was reported by a Physician from JAPAN on Nov 26, 2007. Female patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, . PROGRAF dosage: unknown. Patient died on 01/20/2007.
Rituxan Side Effects Report #5280359-6
Physician from NORWAY reported RITUXAN problem on Mar 12, 2007. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pneumocystis jiroveci pneumonia, . RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5280380-8
RITUXAN problem was reported by a Physician from NORWAY on Mar 12, 2007. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pneumocystis jiroveci pneumonia, . RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5280386-9
Physician from NORWAY reported RITUXAN problem on Mar 12, 2007. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pneumocystis jiroveci pneumonia, . RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5273407-0
RITUXAN problem was reported by a Physician from NORWAY on Mar 07, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pneumocystis jiroveci pneumonia, . RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE. Patient recovered.
Tysabri Side Effects Report #5664291-1
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Mar 04, 2008. Female patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: latent tuberculosis, opportunistic infection, . TYSABRI dosage: 300 MG;QM;IV. Patient recovered.
Tysabri Side Effects Report #5683503-1
TYSABRI problem was reported by a Physician from UNITED STATES on Mar 18, 2008. Male patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: decubitus ulcer, opportunistic infection, urinary tract infection, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5637871-7
Health Professional from UNITED STATES reported TYSABRI problem on Feb 05, 2008. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: catheter related complication, opportunistic infection, sepsis, urinary tract infection, vulvovaginal mycotic infection, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5583989-7
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2007. Male patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: lethargy, opportunistic infection, pneumonia, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Esertia Side Effects Report #5587153-7
Health Professional from SPAIN reported ESERTIA problem on Dec 21, 2007. Male patient, 52 years of age, was diagnosed with depressed mood and was treated with ESERTIA. After drug was administered, patient experienced the following problems/side effects: candidiasis, opportunistic infection, pseudomonas infection, septic shock, subarachnoid haemorrhage, thrombocytopenia, ulcer, . ESERTIA dosage: 10 MG QD PO. During the same period patient was treated with MENOREM, FENITOIN, AMBISOME, VANCOMICIN, ENOXAPARIN, LEVOTHYROXINE, CANCIDAS. Patient died on 10/05/2007.
Kaletra Side Effects Report #5510801-4
KALETRA problem was reported by a Consumer or non-health professional from PERU on Dec 29, 2005. Female patient, 32 years of age, weighting 105.8 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cryptococcosis, opportunistic infection, pneumococcal bacteraemia, . KALETRA dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient recovered.
Natalizumab Side Effects Report #5526169-3
Consumer or non-health professional from SWEDEN reported NATALIZUMAB problem on Nov 06, 2007. Female patient, 44 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: herpes zoster, opportunistic infection, varicella zoster virus serology positive, . NATALIZUMAB dosage: 300 MG; ;IV, 300 MG; ;IV. During the same period patient was treated with TRIOBE. Patient recovered.
Kaletra Side Effects Report #5531133-4
KALETRA problem was reported by a Consumer or non-health professional from PERU on Nov 22, 2007. Female patient, 32 years of age, weighting 105.8 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cryptococcosis, opportunistic infection, pneumococcal bacteraemia, . KALETRA dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5472510-X
Physician from BELGIUM reported TEMODAL problem on Sept 13, 2007. Female patient, 40 years of age, was diagnosed with glioblastoma multiforme and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: neutropenia, opportunistic infection, . TEMODAL dosage: 75 MG/M2;QD. Patient was hospitalized. Patient died on 09/01/2007.
Methotrexate Side Effects Report #5407911-9
METHOTREXATE problem was reported by a Physician from UNITED STATES on July 20, 2007. Female patient, 61 years of age, was diagnosed with rheumatoid arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: histoplasmosis disseminated, opportunistic infection, . METHOTREXATE dosage: 15 MG, WEEKLY. During the same period patient was treated with PREDNISONE, NAPROXEN. Patient recovered.
Rituxan Side Effects Report #5391289-3
Physician from AUSTRALIA reported RITUXAN problem on July 13, 2007. Male patient, 48 years of age, was diagnosed with pemphigus and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: neutropenia, opportunistic infection, pneumonia, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with ACETAMINOPHEN, LORATADINE, PREDNISOLONE, MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5391289-3
RITUXAN problem was reported by a Physician from AUSTRALIA on July 13, 2007. Male patient, 48 years of age, was diagnosed with pemphigus and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: neutropenia, opportunistic infection, pneumonia, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with ACETAMINOPHEN, LORATADINE, PREDNISOLONE, MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Humira Side Effects Report #5767570-2
Pharmacist from UNITED STATES reported HUMIRA problem on June 11, 2008. Female patient, 80 years of age, weighting 183.0 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: immunosuppression, opportunistic infection, . HUMIRA dosage: 40 MG EVERY 2 WEEKS SQ. Patient died on 04/29/2008.
Tysabri Side Effects Report #5694180-8
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2008. Female patient, 37 years of age, weighting 200.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: abscess, opportunistic infection, optic neuritis, wound infection staphylococcal, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5359484-7
Physician from AUSTRALIA reported RITUXAN problem on June 08, 2007. Male patient, 48 years of age, was diagnosed with pemphigus and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: neutropenia, opportunistic infection, pneumonia, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with PARACETAMOL, LORATADINE, PREDNISOLONE, MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5660147-9
TYSABRI problem was reported by a Physician from UNITED STATES on Feb 22, 2008. Male patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: decubitus ulcer, opportunistic infection, urinary tract infection, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
Escitalopram Side Effects Report #5663924-3
Consumer or non-health professional from SPAIN reported ESCITALOPRAM problem on Feb 20, 2008. Male patient, 52 years of age, was diagnosed with depressed mood and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: candidiasis, opportunistic infection, pseudomonas infection, septic shock, skin necrosis, subarachnoid haemorrhage, thrombocytopenia, . ESCITALOPRAM dosage: 10 MG QD PO. During the same period patient was treated with MENOREM, FENITOIN, AMBISOME, VANCOMYCIN, ENOXAPARIN, LEVOTHYROXINE, CANCIDAS. Patient died on 10/05/2007.
Natalizumab Side Effects Report #5565352-8
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2007. Female patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: dysphagia, mycobacterium avium complex infection, opportunistic infection, respiratory disorder, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient recovered.
Temodal Side Effects Report #5467933-9
Physician from BELGIUM reported TEMODAL problem on Sept 13, 2007. Female patient, 40 years of age, was diagnosed with glioblastoma multiforme and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: coma, neutropenia, opportunistic infection, . TEMODAL dosage: 75 MG/M2; QD. Patient was hospitalized. Patient died on 09/01/2007.
Natalizumab Side Effects Report #5467950-9
NATALIZUMAB problem was reported by a Physician from SWEDEN on Sept 14, 2007. Female patient was diagnosed with relapsing-remitting multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: herpes zoster, incorrect dose administered, opportunistic infection, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5778163-5
Physician from UNITED STATES reported TYSABRI problem on June 03, 2008. Female patient was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: convulsion, haemophilus infection, opportunistic infection, sinusitis, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5727328-7
TYSABRI problem was reported by a Health Professional from UNITED STATES on Apr 18, 2008. Female patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: computerised tomogram abnormal, latent tuberculosis, opportunistic infection, . TYSABRI dosage: 300 MG;QM;IV. Patient recovered.
Temodal Side Effects Report #5258554-1
Physician from FRANCE reported TEMODAL problem on Feb 23, 2007. Female patient was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: cryptococcosis, meningeal disorder, opportunistic infection, . TEMODAL dosage: 150 MG/M2; QD;. During the same period patient was treated with VINCRISTINE, CARBOPLATIN. Patient was hospitalized. Patient recovered.